Paramount stock rises after FCC approves Skydance merger
LONDON - Creo Medical (TASE:BLWV) Group plc (AIM:CREO), a company specializing in minimally invasive surgical endoscopy, has announced the publication of its 2024 Annual Report and Accounts and the scheduling of its Annual General Meeting (AGM). The AGM is set to take place at 10:00am on Thursday, June 26, 2025, at the offices of Osborne Clarke LLP in Bristol.
The company, which provides innovative medical devices for pre-cancer and cancer patient care, has made the report and AGM notice available on its website. Hard copies have been sent to shareholders who prefer physical documents. The AGM will feature a short presentation by CEO Craig Gulliford, although it has been stated that no new material information will be presented.
Shareholders are encouraged to vote by proxy, with options to submit their Form of Proxy to Equiniti or use the CREST electronic proxy appointment service for members. The deadline for proxy votes is set for 10:00am on June 24, 2025. The company advises shareholders to appoint the Chair of the meeting as their proxy to avoid any complications should a named person be unable to attend due to unforeseen circumstances.
The voting at the AGM will be conducted by poll. This announcement is based on a press release statement from Creo Medical Group.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.